首页 > 最新文献

Acta Psychiatrica Scandinavica最新文献

英文 中文
Cognition in Psychiatry: Treatment Targets, Mechanisms, and Assessment Innovations. 精神病学中的认知:治疗目标、机制和评估创新。
IF 5.3 2区 医学 Q1 PSYCHIATRY Pub Date : 2025-07-22 DOI: 10.1111/acps.70015
Kamilla W Miskowiak, Katherine E Burdick
{"title":"Cognition in Psychiatry: Treatment Targets, Mechanisms, and Assessment Innovations.","authors":"Kamilla W Miskowiak, Katherine E Burdick","doi":"10.1111/acps.70015","DOIUrl":"https://doi.org/10.1111/acps.70015","url":null,"abstract":"","PeriodicalId":108,"journal":{"name":"Acta Psychiatrica Scandinavica","volume":" ","pages":""},"PeriodicalIF":5.3,"publicationDate":"2025-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144688431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of Improvement in Subjective Executive Functioning Following an Internet-Delivered Cognitive Enhancement Intervention for Adults in Remission From Depression. 网络认知增强干预对抑郁症缓解成人主观执行功能改善的预测因素。
IF 5.3 2区 医学 Q1 PSYCHIATRY Pub Date : 2025-07-20 DOI: 10.1111/acps.70019
Sunniva Brurok Myklebost, Tine Nordgreen, Eivind Haga Ronold, Aleksander Heltne, Åsa Hammar

Introduction: Residual cognitive deficits are commonly reported by individuals in remission from depression, often affecting daily life functioning and mental health. To provide tailored and personalized cognitive enhancement interventions for this population, there is a need for a better understanding of the characteristics of those who benefit from such interventions. Therefore, this study aimed to identify predictors of changes in subjective executive functioning following an internet-delivered cognitive enhancement intervention for adults in remission from depression.

Methods: Data were collected from a randomized controlled trial investigating the efficacy of an internet-delivered cognitive enhancement intervention. Changes in subjective executive functioning from pre-treatment to the six-month follow-up were assessed in 44 participants in remission from depression, using the Behavior Rating Inventory of Executive Function Adult Global Executive Composite. Linear mixed model analyses were conducted to investigate the impact of demographic, clinical, and treatment credibility variables on change in subjective cognitive functioning over time.

Results: The results showed that shorter lifetime depression duration predicted greater improvements in subjective executive functioning (p = 0.031). Higher levels of treatment expectancy and credibility were related to greater improvements in subjective cognitive functioning (p = 0.024). Participants with a partner showed better treatment response than those without a partner (p < 0.001).

Conclusion: This study builds on previous research on cognitive enhancement interventions in remitted depression, highlighting the impact of depression duration, treatment expectancy, and credibility on treatment response. Interventions targeting cognitive deficits appear most effective for those with a shorter lifetime duration of depression. Therefore, efforts should be made to enhance outcomes in those with a chronic course. To maximize engagement and outcomes, these interventions should be delivered in a way that individuals in remission from depression view them as credible and capable of reducing their deficits. Previous research has not found partner status to predict change in subjective executive functioning. The effect of partner status on treatment response should be investigated further.

残馀认知缺陷通常在抑郁症缓解期的个体中报告,经常影响日常生活功能和心理健康。为了为这一人群提供量身定制和个性化的认知增强干预措施,需要更好地了解从这些干预措施中受益的人的特征。因此,本研究旨在确定对抑郁症缓解的成年人进行互联网认知增强干预后主观执行功能变化的预测因素。方法:从一项随机对照试验中收集数据,研究互联网提供的认知增强干预的疗效。使用执行功能成人全球执行综合行为评定量表,对44名抑郁症缓解者的主观执行功能从治疗前到6个月随访期间的变化进行了评估。采用线性混合模型分析来调查人口统计学、临床和治疗可信度变量随时间变化对主观认知功能变化的影响。结果:抑郁持续时间越短,主观执行功能改善越显著(p = 0.031)。更高水平的治疗期望和可信度与主观认知功能的更大改善相关(p = 0.024)。结论:本研究建立在先前关于认知增强干预对抑郁症缓解的研究基础上,强调了抑郁症持续时间、治疗预期和可信度对治疗反应的影响。针对认知缺陷的干预措施似乎对那些一生持续时间较短的抑郁症患者最有效。因此,应努力提高慢性病程患者的预后。为了最大限度地提高参与度和效果,这些干预措施应该以一种方式进行,即抑郁症缓解的个体认为这些干预措施是可信的,能够减少他们的缺陷。先前的研究没有发现伴侣状态可以预测主观执行功能的变化。伴侣状态对治疗反应的影响有待进一步研究。
{"title":"Predictors of Improvement in Subjective Executive Functioning Following an Internet-Delivered Cognitive Enhancement Intervention for Adults in Remission From Depression.","authors":"Sunniva Brurok Myklebost, Tine Nordgreen, Eivind Haga Ronold, Aleksander Heltne, Åsa Hammar","doi":"10.1111/acps.70019","DOIUrl":"https://doi.org/10.1111/acps.70019","url":null,"abstract":"<p><strong>Introduction: </strong>Residual cognitive deficits are commonly reported by individuals in remission from depression, often affecting daily life functioning and mental health. To provide tailored and personalized cognitive enhancement interventions for this population, there is a need for a better understanding of the characteristics of those who benefit from such interventions. Therefore, this study aimed to identify predictors of changes in subjective executive functioning following an internet-delivered cognitive enhancement intervention for adults in remission from depression.</p><p><strong>Methods: </strong>Data were collected from a randomized controlled trial investigating the efficacy of an internet-delivered cognitive enhancement intervention. Changes in subjective executive functioning from pre-treatment to the six-month follow-up were assessed in 44 participants in remission from depression, using the Behavior Rating Inventory of Executive Function Adult Global Executive Composite. Linear mixed model analyses were conducted to investigate the impact of demographic, clinical, and treatment credibility variables on change in subjective cognitive functioning over time.</p><p><strong>Results: </strong>The results showed that shorter lifetime depression duration predicted greater improvements in subjective executive functioning (p = 0.031). Higher levels of treatment expectancy and credibility were related to greater improvements in subjective cognitive functioning (p = 0.024). Participants with a partner showed better treatment response than those without a partner (p < 0.001).</p><p><strong>Conclusion: </strong>This study builds on previous research on cognitive enhancement interventions in remitted depression, highlighting the impact of depression duration, treatment expectancy, and credibility on treatment response. Interventions targeting cognitive deficits appear most effective for those with a shorter lifetime duration of depression. Therefore, efforts should be made to enhance outcomes in those with a chronic course. To maximize engagement and outcomes, these interventions should be delivered in a way that individuals in remission from depression view them as credible and capable of reducing their deficits. Previous research has not found partner status to predict change in subjective executive functioning. The effect of partner status on treatment response should be investigated further.</p>","PeriodicalId":108,"journal":{"name":"Acta Psychiatrica Scandinavica","volume":" ","pages":""},"PeriodicalIF":5.3,"publicationDate":"2025-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144673385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Healthcare Occupations, Suicides, and Suicide Attempts: A Cohort Study Based on the Working Population in Sweden 医疗保健职业、自杀和自杀企图:一项基于瑞典工作人口的队列研究
IF 5 2区 医学 Q1 PSYCHIATRY Pub Date : 2025-07-20 DOI: 10.1111/acps.70018
Alicia Nevriana, Emma Brulin, Tomas Hemmingsson, Melody Almroth, Kuan-Yu Pan, Theo Bodin, Katarina Kjellberg, Daniel Falkstedt

Introduction

Many studies have examined physicians' risk of suicide, but studies of other healthcare occupations have been fewer. Suicide attempts have also rarely been studied. We aimed to determine the risks of suicide and suicide attempts among healthcare workers in comparison with non-healthcare workers, according to occupational qualification level.

Methods

This population-based cohort study linking Swedish national registers included 243,183 healthcare workers in high-qualified occupations (e.g., physicians); 1,789,076 workers in other high-qualified occupations; 514,726 healthcare workers in low-qualified occupations (e.g., assistant nurses); and 2,026,890 workers in low-qualified occupations residing in Sweden in 2005 and followed them until the latest December 31, 2020. We estimated adjusted hazard ratios (aHR) for suicide and first suicide attempt.

Results

Compared to non-healthcare workers, higher risks for suicide were observed for several healthcare occupations, primarily those working with patient care (e.g., aHR physicians 1.57, 95% CI: 1.23–2.00, registered nurses 1.61, 95% CI: 1.37–1.88, assistant nurses 1.25, 95% CI: 1.17–1.34), rather than those in administrative roles (aHR high-qualified healthcare administrators 1.01 95% CI: 0.76–1.35). Among physicians, the risk was most apparent for psychiatrists (aHR 2.70, 95% CI: 1.21–6.03). For suicide attempts, the risks were primarily observed among registered nurses (aHR 1.22, 95% CI: 1.15–1.29) and assistant nurses (aHR 1.15, 95% CI: 1.12–1.18). Among healthcare workers, assistant nurses had the highest incidence rates for suicide (18.7/100,000 person-years) and suicide attempts (175.1/100,000 person-years).

Conclusions

Workers in several healthcare occupations showed a higher risk of suicide relative to non-healthcare workers with a similar occupational qualification level. Interventions may need to be developed to reduce the risk of suicidal behavior in these groups.

许多研究已经调查了医生的自杀风险,但对其他医疗保健职业的研究较少。自杀企图也很少被研究过。我们的目的是根据职业资格水平确定医护人员与非医护人员自杀和企图自杀的风险。方法:这项以人群为基础的队列研究将瑞典国家登记册纳入243,183名高质量职业(如医生)的卫生保健工作者;其他高技能职业人员1,789,076人;514,726名从事低资格职业的卫生保健工作者(如助理护士);2005年居住在瑞典的2026890名从事低资格职业的工人,并一直追踪到2020年12月31日。我们估计了自杀和首次自杀企图的调整风险比(aHR)。结果:与非卫生保健工作者相比,在一些卫生保健职业中观察到较高的自杀风险,主要是那些从事病人护理工作的人(例如,aHR医生1.57,95% CI: 1.23-2.00,注册护士1.61,95% CI: 1.37-1.88,助理护士1.25,95% CI: 1.17-1.34),而不是那些担任行政职务的人(aHR高素质卫生保健管理人员1.01,95% CI: 0.76-1.35)。在医生中,精神科医生的风险最为明显(aHR 2.70, 95% CI: 1.21-6.03)。对于自杀企图,主要观察到注册护士(aHR 1.22, 95% CI: 1.15-1.29)和助理护士(aHR 1.15, 95% CI: 1.12-1.18)的风险。在医护人员中,助理护士的自杀率最高(18.7/10万人-年),自杀未遂率最高(175.1/10万人-年)。结论:与具有相似职业资格水平的非卫生保健工作者相比,一些卫生保健职业的工作者显示出更高的自杀风险。可能需要制定干预措施,以降低这些群体的自杀行为风险。
{"title":"Healthcare Occupations, Suicides, and Suicide Attempts: A Cohort Study Based on the Working Population in Sweden","authors":"Alicia Nevriana,&nbsp;Emma Brulin,&nbsp;Tomas Hemmingsson,&nbsp;Melody Almroth,&nbsp;Kuan-Yu Pan,&nbsp;Theo Bodin,&nbsp;Katarina Kjellberg,&nbsp;Daniel Falkstedt","doi":"10.1111/acps.70018","DOIUrl":"10.1111/acps.70018","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Many studies have examined physicians' risk of suicide, but studies of other healthcare occupations have been fewer. Suicide attempts have also rarely been studied. We aimed to determine the risks of suicide and suicide attempts among healthcare workers in comparison with non-healthcare workers, according to occupational qualification level.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This population-based cohort study linking Swedish national registers included 243,183 healthcare workers in high-qualified occupations (e.g., physicians); 1,789,076 workers in other high-qualified occupations; 514,726 healthcare workers in low-qualified occupations (e.g., assistant nurses); and 2,026,890 workers in low-qualified occupations residing in Sweden in 2005 and followed them until the latest December 31, 2020. We estimated adjusted hazard ratios (aHR) for suicide and first suicide attempt.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Compared to non-healthcare workers, higher risks for suicide were observed for several healthcare occupations, primarily those working with patient care (e.g., aHR physicians 1.57, 95% CI: 1.23–2.00, registered nurses 1.61, 95% CI: 1.37–1.88, assistant nurses 1.25, 95% CI: 1.17–1.34), rather than those in administrative roles (aHR high-qualified healthcare administrators 1.01 95% CI: 0.76–1.35). Among physicians, the risk was most apparent for psychiatrists (aHR 2.70, 95% CI: 1.21–6.03). For suicide attempts, the risks were primarily observed among registered nurses (aHR 1.22, 95% CI: 1.15–1.29) and assistant nurses (aHR 1.15, 95% CI: 1.12–1.18). Among healthcare workers, assistant nurses had the highest incidence rates for suicide (18.7/100,000 person-years) and suicide attempts (175.1/100,000 person-years).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Workers in several healthcare occupations showed a higher risk of suicide relative to non-healthcare workers with a similar occupational qualification level. Interventions may need to be developed to reduce the risk of suicidal behavior in these groups.</p>\u0000 </section>\u0000 </div>","PeriodicalId":108,"journal":{"name":"Acta Psychiatrica Scandinavica","volume":"152 5","pages":"360-371"},"PeriodicalIF":5.0,"publicationDate":"2025-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/acps.70018","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144673384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bipolar Disorder and Poisoning due to Medicines or Illegal Substances 双相情感障碍和药物或非法物质中毒。
IF 5 2区 医学 Q1 PSYCHIATRY Pub Date : 2025-07-17 DOI: 10.1111/acps.70017
Mikko Niskanen, Olli Kärkkäinen, Heidi Taipale, Johannes Lieslehto, Jari Tiihonen, Aleksi Hamina

Background

Individuals with bipolar disorder face an elevated risk of premature death, often due to external causes such as accidental injuries, self-harm, and substance-related deaths. This study aimed to investigate the incidence of severe poisonings among individuals with bipolar disorder and to examine associated demographic and clinical factors.

Methods

We conducted a cohort study using data from national registers in Finland, measuring hospitalizations and deaths due to poisoning by medicines or illegal substances in 1996–2018. Cox proportional hazards regression models were used to assess associations between predictor variables and poisoning outcomes.

Results

The study population comprised 60,045 individuals aged 15–65 diagnosed with bipolar disorder in 1987–2018. During the study period, 13.1% (N = 7872) of the population experienced at least one poisoning resulting in hospitalization or death. The age-standardized rate of hospitalizations was 50.6 (95% CI, 49.5–51.7) per 1000 person-years and of deaths 1.8 (95% CI, 1.6–2.0) per 1000 person-years. The majority of poisonings leading to hospitalization (59.1%) or death (56.6%) were intentional and caused by pharmaceuticals (hospitalizations, 76.9%; deaths, 63.6%). Additionally, psychoactive narcotics and stimulants were the cause of 26.8% of the poisoning deaths. The strongest risk factors for hospitalization were substance use disorder (adjusted hazard ratio, aHR, 2.75, 95% CI, 2.61–2.90) and a history of suicide attempt (2.70, 2.52–2.88). The risk of poisoning death was most strongly associated with substance use disorder (3.02, 2.60–3.52) and a history of suicide attempt (2.38, 1.94–2.91). Female sex was associated with a higher risk of hospitalization (1.19, 1.14–1.25), but a lower risk of death (0.72, 0.62–0.82).

Conclusion

Individuals with bipolar disorder face a substantial risk of poisoning by medicines or illegal substances, with notable sex differences in hospitalization and death rates. Key risk factors include substance use disorder and a history of suicide attempt.

背景:双相情感障碍患者面临着较高的过早死亡风险,通常是由于外部原因,如意外伤害、自残和物质相关死亡。本研究旨在调查双相情感障碍患者中严重中毒的发生率,并检查相关的人口统计学和临床因素。方法:我们使用芬兰国家登记处的数据进行了一项队列研究,测量了1996-2018年期间因药物或非法物质中毒而住院和死亡的情况。Cox比例风险回归模型用于评估预测变量与中毒结局之间的关联。结果:研究人群包括60,045名年龄在15-65岁之间的人,他们在1987-2018年被诊断为双相情感障碍。在研究期间,13.1% (N = 7872)的人群经历了至少一次导致住院或死亡的中毒。年龄标准化住院率为50.6 (95% CI, 49.5-51.7) / 1000人年,死亡率为1.8 (95% CI, 1.6-2.0) / 1000人年。大多数导致住院(59.1%)或死亡(56.6%)的中毒是故意的,是由药物引起的(住院,76.9%;死亡,63.6%)。此外,精神活性麻醉品和兴奋剂占中毒死亡的26.8%。住院的最强危险因素是物质使用障碍(校正风险比,aHR, 2.75, 95% CI, 2.61-2.90)和自杀企图史(2.70,2.52-2.88)。中毒死亡的风险与物质使用障碍(3.02,2.60-3.52)和自杀企图史(2.38,1.94-2.91)密切相关。女性住院风险较高(1.19,1.14-1.25),但死亡风险较低(0.72,0.62-0.82)。结论:双相情感障碍患者存在很大的药物或非法物质中毒风险,其住院率和死亡率存在显著的性别差异。主要的危险因素包括物质使用障碍和自杀企图史。
{"title":"Bipolar Disorder and Poisoning due to Medicines or Illegal Substances","authors":"Mikko Niskanen,&nbsp;Olli Kärkkäinen,&nbsp;Heidi Taipale,&nbsp;Johannes Lieslehto,&nbsp;Jari Tiihonen,&nbsp;Aleksi Hamina","doi":"10.1111/acps.70017","DOIUrl":"10.1111/acps.70017","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Individuals with bipolar disorder face an elevated risk of premature death, often due to external causes such as accidental injuries, self-harm, and substance-related deaths. This study aimed to investigate the incidence of severe poisonings among individuals with bipolar disorder and to examine associated demographic and clinical factors.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We conducted a cohort study using data from national registers in Finland, measuring hospitalizations and deaths due to poisoning by medicines or illegal substances in 1996–2018. Cox proportional hazards regression models were used to assess associations between predictor variables and poisoning outcomes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The study population comprised 60,045 individuals aged 15–65 diagnosed with bipolar disorder in 1987–2018. During the study period, 13.1% (<i>N</i> = 7872) of the population experienced at least one poisoning resulting in hospitalization or death. The age-standardized rate of hospitalizations was 50.6 (95% CI, 49.5–51.7) per 1000 person-years and of deaths 1.8 (95% CI, 1.6–2.0) per 1000 person-years. The majority of poisonings leading to hospitalization (59.1%) or death (56.6%) were intentional and caused by pharmaceuticals (hospitalizations, 76.9%; deaths, 63.6%). Additionally, psychoactive narcotics and stimulants were the cause of 26.8% of the poisoning deaths. The strongest risk factors for hospitalization were substance use disorder (adjusted hazard ratio, aHR, 2.75, 95% CI, 2.61–2.90) and a history of suicide attempt (2.70, 2.52–2.88). The risk of poisoning death was most strongly associated with substance use disorder (3.02, 2.60–3.52) and a history of suicide attempt (2.38, 1.94–2.91). Female sex was associated with a higher risk of hospitalization (1.19, 1.14–1.25), but a lower risk of death (0.72, 0.62–0.82).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Individuals with bipolar disorder face a substantial risk of poisoning by medicines or illegal substances, with notable sex differences in hospitalization and death rates. Key risk factors include substance use disorder and a history of suicide attempt.</p>\u0000 </section>\u0000 </div>","PeriodicalId":108,"journal":{"name":"Acta Psychiatrica Scandinavica","volume":"152 4","pages":"299-307"},"PeriodicalIF":5.0,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/acps.70017","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144657913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Life Expectancy, Loss of Life Expectancy, and Lifetime Costs in Bipolar Disorder: A Nationwide Population-Based Study 双相情感障碍的预期寿命、预期寿命损失和终生成本:一项基于全国人群的研究。
IF 5 2区 医学 Q1 PSYCHIATRY Pub Date : 2025-07-15 DOI: 10.1111/acps.70013
Ikbal Andrian Malau, Ying-Ming Chiu, Hui-Chih Chang, Ya-Chu Yang, Jane Pei-Chen Chang, Christoph U. Correll, Vieta Eduard, Kuan-Pin Su

Introduction

Bipolar disorder (BD) significantly affects life expectancy (LE), results in substantial loss of LE, and contributes to high medical costs, with these impacts varying by age at onset and gender. Previous studies have often overlooked the significance of age at the onset when estimating LE in individuals with BD. This study aimed to address this limitation and assess the impacts of BD on LE, loss of LE, and medical costs for BD patients categorized by age and gender in Taiwan using a new semiparametric extrapolation method over an 11-year duration.

Methods

A rolling-over algorithm estimated the survival function, with lifetime risk extrapolated. LE and loss of LE were calculated by comparing BD patients to matched non-BD referents by sex, age, and diagnosis year. Lifetime medical costs were determined by multiplying average monthly expenses by survival rates. Data from Taiwan's National Health Insurance (2009–2019) identified BD patients aged 5–84 with ≥ 2 outpatient or ≥ 1 inpatient BD diagnosis. The semiparametric survival extrapolation method was validated by comparing it with the Kaplan–Meier analysis.

Results

The results indicate that following a BD diagnosis, patients have an LE of 26.79 years, reflecting a loss of 15.08 years compared to matched referents. On average, patients with BD incurred annual medical expenses of around $2516, with costs rising with age for both sexes. The mean estimated lifetime cost for the study population was about $55,015. The extrapolation method demonstrated high accuracy, with a less than 5% relative bias.

Conclusion

Semiparametric extrapolation is an effective method for estimating LE, loss of LE, and lifetime costs in BD. Future work could refine semiparametric extrapolation and assess factors influencing LE loss and lifetime costs in BD.

导读:双相情感障碍(BD)显著影响预期寿命(LE),导致预期寿命的大量丧失,并导致高昂的医疗费用,这些影响因发病年龄和性别而异。以往的研究在估计双相障碍患者的LE时往往忽略了发病年龄的重要性。本研究旨在解决这一局限性,并采用一种新的半参数外推法,评估台湾按年龄和性别分类的双相障碍患者的BD对LE、LE损失和医疗费用的影响。方法:用滚动算法估计生存函数,并外推终生风险。通过将BD患者与匹配的非BD患者按性别、年龄和诊断年份进行比较,计算LE和LE损失。终生医疗费用由平均每月费用乘以存活率确定。​通过与Kaplan-Meier分析的比较,验证了半参数生存外推法的有效性。结果:结果表明,在BD诊断后,患者的LE为26.79年,与匹配的参照对象相比减少了15.08年。平均而言,BD患者每年的医疗费用约为2516美元,并且随着年龄的增长,男女患者的医疗费用都在上升。研究人群的平均估计终身成本约为55,015美元。外推法具有较高的准确度,相对偏差小于5%。结论:半参数外推法是估计BD中LE、LE损失和生命周期成本的有效方法,未来的工作可以完善半参数外推法,评估影响BD中LE损失和生命周期成本的因素。
{"title":"Life Expectancy, Loss of Life Expectancy, and Lifetime Costs in Bipolar Disorder: A Nationwide Population-Based Study","authors":"Ikbal Andrian Malau,&nbsp;Ying-Ming Chiu,&nbsp;Hui-Chih Chang,&nbsp;Ya-Chu Yang,&nbsp;Jane Pei-Chen Chang,&nbsp;Christoph U. Correll,&nbsp;Vieta Eduard,&nbsp;Kuan-Pin Su","doi":"10.1111/acps.70013","DOIUrl":"10.1111/acps.70013","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Bipolar disorder (BD) significantly affects life expectancy (LE), results in substantial loss of LE, and contributes to high medical costs, with these impacts varying by age at onset and gender. Previous studies have often overlooked the significance of age at the onset when estimating LE in individuals with BD. This study aimed to address this limitation and assess the impacts of BD on LE, loss of LE, and medical costs for BD patients categorized by age and gender in Taiwan using a new semiparametric extrapolation method over an 11-year duration.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A rolling-over algorithm estimated the survival function, with lifetime risk extrapolated. LE and loss of LE were calculated by comparing BD patients to matched non-BD referents by sex, age, and diagnosis year. Lifetime medical costs were determined by multiplying average monthly expenses by survival rates. Data from Taiwan's National Health Insurance (2009–2019) identified BD patients aged 5–84 with ≥ 2 outpatient or ≥ 1 inpatient BD diagnosis. The semiparametric survival extrapolation method was validated by comparing it with the Kaplan–Meier analysis.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The results indicate that following a BD diagnosis, patients have an LE of 26.79 years, reflecting a loss of 15.08 years compared to matched referents. On average, patients with BD incurred annual medical expenses of around $2516, with costs rising with age for both sexes. The mean estimated lifetime cost for the study population was about $55,015. The extrapolation method demonstrated high accuracy, with a less than 5% relative bias.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Semiparametric extrapolation is an effective method for estimating LE, loss of LE, and lifetime costs in BD. Future work could refine semiparametric extrapolation and assess factors influencing LE loss and lifetime costs in BD.</p>\u0000 </section>\u0000 </div>","PeriodicalId":108,"journal":{"name":"Acta Psychiatrica Scandinavica","volume":"152 5","pages":"350-359"},"PeriodicalIF":5.0,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144641299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Demographic and Clinical Characteristics of Lithium-Treated Older Adults With Bipolar Disorder: A Replication Study From the Global Aging and Geriatric Experiments in Bipolar Disorder (GAGE-BD) Project 锂治疗老年双相情感障碍的人口学和临床特征:一项来自全球老年双相情感障碍实验(GAGE-BD)项目的复制研究
IF 5 2区 医学 Q1 PSYCHIATRY Pub Date : 2025-07-10 DOI: 10.1111/acps.70016
Orestes V. Forlenza, Ni Xu, Peijun Chen, Soham Rej, Ariel G. Gildengers, Tomas Hajek, Martha Sajatovic, the GAGE-BD initiative

Objectives

To replicate a previous study addressing differences and similarities of older adults with bipolar disorder (OABD) treated with lithium as compared to those treated with other drugs.

Methods

Cross-sectional analysis of a harmonized dataset of the GAGE-BD Project, with over 2 thousand participants enrolled from two recruitment waves, with worldwide representation. Participants were allocated in two treatment groups according to the availability of information about current lithium use (Lithium, n = 754; Non-lithium, n = 1,161). We used linear regression, linear mixed and generalized linear mixed models to examine the associations between treatment groups and other variables, with emphasis on the distribution of socio-demographical and clinical variables, controlling for age, gender, and study site.

Results

We found statistical associations between lithium use and higher education level, as well as with bipolar-1 subtype, and a negative association with comorbid anxiety disorder. OABD patients treated with lithium had lower scores on depression rating scales, and better overall global cognitive and functional state. Lithium users also reported having fewer cardiovascular comorbidities.

Conclusion

We found several potentially relevant differences in the clinical profile of OABD treated with lithium; nonetheless, the interpretation of the present results must take into account the methodological limitations inherent to the cross-sectional approach and data harmonization.

目的重复先前的一项研究,研究锂治疗老年双相情感障碍(OABD)与其他药物治疗的差异和相似之处。方法对GAGE-BD项目的统一数据集进行横断面分析,该数据集从两波招募中招募了2000多名参与者,具有全球代表性。根据当前锂使用信息的可用性,参与者被分配到两个治疗组(锂,n = 754;非锂,n = 1161)。我们使用线性回归、线性混合和广义线性混合模型来检验治疗组与其他变量之间的关联,重点关注社会人口统计学和临床变量的分布,控制年龄、性别和研究地点。结果我们发现锂的使用与高等教育水平以及双相1亚型之间存在统计学相关性,与共病性焦虑症呈负相关。接受锂治疗的OABD患者在抑郁评定量表上得分较低,整体认知和功能状态较好。锂盐使用者报告的心血管合并症也较少。结论我们发现锂治疗OABD的临床特征存在一些潜在的相关差异;然而,对目前结果的解释必须考虑到横断面方法和数据协调所固有的方法局限性。
{"title":"Demographic and Clinical Characteristics of Lithium-Treated Older Adults With Bipolar Disorder: A Replication Study From the Global Aging and Geriatric Experiments in Bipolar Disorder (GAGE-BD) Project","authors":"Orestes V. Forlenza,&nbsp;Ni Xu,&nbsp;Peijun Chen,&nbsp;Soham Rej,&nbsp;Ariel G. Gildengers,&nbsp;Tomas Hajek,&nbsp;Martha Sajatovic,&nbsp;the GAGE-BD initiative","doi":"10.1111/acps.70016","DOIUrl":"https://doi.org/10.1111/acps.70016","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>To replicate a previous study addressing differences and similarities of older adults with bipolar disorder (OABD) treated with lithium as compared to those treated with other drugs.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Cross-sectional analysis of a harmonized dataset of the GAGE-BD Project, with over 2 thousand participants enrolled from two recruitment waves, with worldwide representation. Participants were allocated in two treatment groups according to the availability of information about current lithium use (Lithium, n = 754; Non-lithium, n = 1,161). We used linear regression, linear mixed and generalized linear mixed models to examine the associations between treatment groups and other variables, with emphasis on the distribution of socio-demographical and clinical variables, controlling for age, gender, and study site.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>We found statistical associations between lithium use and higher education level, as well as with bipolar-1 subtype, and a negative association with comorbid anxiety disorder. OABD patients treated with lithium had lower scores on depression rating scales, and better overall global cognitive and functional state. Lithium users also reported having fewer cardiovascular comorbidities.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>We found several potentially relevant differences in the clinical profile of OABD treated with lithium; nonetheless, the interpretation of the present results must take into account the methodological limitations inherent to the cross-sectional approach and data harmonization.</p>\u0000 </section>\u0000 </div>","PeriodicalId":108,"journal":{"name":"Acta Psychiatrica Scandinavica","volume":"152 5","pages":"393-396"},"PeriodicalIF":5.0,"publicationDate":"2025-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145196697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychosis and Dementia—Disorders of Disadvantage 精神病和痴呆——不利障碍。
IF 5 2区 医学 Q1 PSYCHIATRY Pub Date : 2025-07-06 DOI: 10.1111/acps.70012
Lucy Gibson, Christoph Mueller, Robert Stewart
<p>As any Old Age Psychiatrist will tell you, late-life affective and psychotic disorders are some of the least understood mental health conditions, particularly considering their impact and the large number of people affected. This lack of attention partly lies in the common mundane situation of overshadowing research interests. Mental health research in older adults focuses almost entirely on dementia, while research into affective and psychotic disorders focuses almost entirely on young adults. Unfortunately, lack of research translates into an impoverished evidence base, which in turn filters through to underrepresentation in healthcare policy, and this compounds the problem by reducing the likelihood of interest from research funders, impeding capacity building and perpetuating a vicious cycle of inattention which does no favours for patients or health services. Even within the field, there are inequalities in research evidence, with considerably more attention paid to late-onset syndromes than to those who may have been living with their earlier-onset condition for decades by the time they reach older age ranges.</p><p>However, considering late-life psychosis, overshadowing research priorities are only part of the problem, as the conditions themselves present sizeable intrinsic challenges. The social withdrawal that characterises late-onset psychosis limits the likelihood of people affected being represented in conventional recruited research samples or retained in any study involving follow-up [<span>1</span>]. Furthermore, people with earlier-onset diagnoses are frequently out of contact with mental health services by the time they reach ‘older adult’ age ranges, so that it is difficult to identify potential participants for approaching in the first place. Conventional case control, cohort and intervention studies are therefore logistically formidable, if not wholly impractical and/or fundamentally limited by participation and/or attrition bias.</p><p>The growing availability of routine healthcare data for research provides important opportunities for improving the evidence base. Most national data governance frameworks permit the use of effectively anonymised healthcare information to be used for research which enables the better representation of populations who would previously have been considered ‘hard to reach’ in conventional recruited samples. This advantage is exemplified in the approach taken by Normark et al. [<span>2</span>], described in this issue, using national data from Denmark to investigate dementia incidence in people with schizophrenia and related disorders (ICD-10 F2x) according to their age at first psychosis diagnosis or treatment. There are reasonable considerations about the required reliance on recorded diagnoses (given that both conditions may be under-diagnosed, particularly dementia, and that under-diagnosis is unlikely to be at random); however, it is difficult to see how the question could be addressed in a
正如任何一位老年精神病学家都会告诉你的那样,晚年情感和精神障碍是一些最不为人所知的精神健康状况,特别是考虑到它们的影响和受影响的人数众多。这种缺乏关注的部分原因在于研究兴趣被掩盖的常见世俗情况。老年人的心理健康研究几乎完全集中在痴呆症上,而对情感和精神障碍的研究几乎完全集中在年轻人身上。不幸的是,缺乏研究转化为一个贫乏的证据基础,这反过来又过滤到医疗保健政策中代表性不足,这使问题复杂化,因为降低了研究资助者感兴趣的可能性,阻碍了能力建设,并使忽视的恶性循环永久化,这对患者或卫生服务都没有好处。即使在这个领域内,研究证据也存在不平等现象,人们更多地关注晚发综合症,而不是那些可能在早发病症中生活了几十年的人,直到他们进入老年。然而,考虑到老年精神病,掩盖研究重点只是问题的一部分,因为这些条件本身就带来了相当大的内在挑战。迟发性精神病的特征是社交退缩,这限制了受影响的人在常规招募的研究样本中被代表的可能性,也限制了在任何涉及后续研究的研究中被保留的可能性。此外,患有早期发病诊断的人往往在达到“老年人”年龄范围时就与精神卫生服务失去了联系,因此很难首先确定潜在的参与者。因此,传统的病例对照、队列和干预研究即使不是完全不切实际和/或从根本上受到参与和/或流失偏见的限制,在后勤上也是令人望而畏惧的。越来越多的常规医疗保健数据可用于研究,为改善证据基础提供了重要机会。大多数国家数据治理框架允许将有效匿名的医疗保健信息用于研究,从而更好地代表以前在传统招募样本中被认为“难以接触到”的人群。这一优势在Normark等人所采用的方法中得到了体现。本期报道了Normark等人使用丹麦的国家数据,根据首次精神病诊断或治疗的年龄调查精神分裂症及相关疾病患者的痴呆发病率(icd - 10f2x)。需要对记录诊断的依赖有合理的考虑(考虑到这两种情况都可能被诊断不足,尤其是痴呆症,而且诊断不足不太可能是随机的);然而,很难看到如何用其他方式来解决这个问题。关于迟发性精神障碍和痴呆之间关系的观点随着时间的推移发生了变化,从早期的结论认为迟发性精神分裂症样精神病[3]中没有有机成分,到越来越多的人认识到它可能是痴呆的常见前驱症状,可能类似于更广泛描述的迟发性抑郁症和痴呆[4]之间的关系。特别是,现在有几项研究已经证实,被诊断为老年精神病的人患痴呆症的发病率更高,在老年精神病发病后的第一年,风险往往最大[5,6]。此外,神经病理改变似乎在晚发性精神分裂症中更为常见,这表明这些个体中至少有一部分可能处于神经退行性疾病[7]的前驱期。事实上,早期精神病症状与患阿尔茨海默病的风险增加有关,此外,认知能力下降的速度也更快。然而,Normark等人的目标是,在生命早期首次诊断出精神障碍的患者中,人们对痴呆症的风险知之甚少。Normark等人也发现,早发性精神障碍患者患痴呆的风险更高,证实了先前荟萃分析的结论。这一点也不奇怪。在患有精神障碍或“严重精神疾病”的人群中,已经描述了许多不良的健康结果,包括长期以来公认的普遍增加的死亡率和更高的心血管终点,特别是bbb。这反过来又反映了糖尿病、肥胖和代谢综合征以及不良生活方式因素(如缺乏身体活动、不理想的饮食和吸烟)造成的血管风险因素更糟。痴呆症风险的增加与所有这些因素有关,也与更普遍的社会经济劣势和社会孤立有关,精神分裂症患者可能特别容易受到社会孤立的影响。 早发性精神障碍还与较低的教育水平有关,这有助于减少认知储备,进而可能降低痴呆症的阈值。抗胆碱能和其他与抗精神病药物使用相关的(如镇静)作用可能会进一步加剧风险,而且至少与一些精神障碍相关的认知障碍(包括注意力、工作记忆和执行功能缺陷)也可能导致痴呆前储备减少。神经退行性改变是另一个可能以多种方式增加痴呆潜在疾病风险的因素,包括由小脑梗死和大脑梗死引起的血管性痴呆,以及由促炎状态引起的阿尔茨海默病和/或由于脑血管疾病程度较轻和认知储备减少而加速发病。然而,最近的一项荟萃分析得出,与健康对照组相比,慢性精神病相关认知障碍患者的AD病理发生率相似,这表明与早发性精神病相关的痴呆主要不是由神经退行性改变驱动的。在早期和晚发性精神病患者中,导致痴呆风险增加的机制可能有所不同,神经退行性病理改变在早期发展为精神病的个体中不太明显。可以说,过去20-30年流行病学研究的贡献在于将精神病和痴呆症重新定义为“不利障碍”。对于痴呆症,早期的研究范式仅限于遗传和脑损伤等离散的风险因素,20世纪90年代中期的证据扩大了对病因的理解,包括血管疾病和不良生活方式,所有这些都被认为是强烈的社会决定因素,并从出生开始积累,与教育和早期生活的认知成就一起决定了后来的大脑储备。事实上,很少有导致过早死亡的常见风险因素没有被发现与那些存活下来的人患痴呆症的风险更高有关,所以这里发现的与精神病的关联只是与更广泛的图景相吻合。就精神病而言,随着人们越来越认识到社会因素在其自身发展中的作用,过去对精神健康结果的狭隘关注在过去几十年中也同样扩大,以涵盖受影响者面临的更广泛的健康差距。因此,这里观察到的与痴呆风险增加的关联,再次简单地适应为长期不利的最终结果。那么,这将带给我们什么呢?最近的共识声明强调了预防许多痴呆症病例的潜力,只要推迟其发病,使其在生活中不发生(或仅在轻度阶段发生)。预防所需的行动主要是那些为改善健康状况而推荐的行动——更好的饮食、体育活动、社会支持、良好控制的健康状况等等。精神病患者从这些改善健康的举措中获益最多,但往往获得的机会最少。在潜在的益处列表中加入预防痴呆症是否有助于改善获取还不确定,但似乎至少值得评估。更直接的是,在对患有精神分裂症和其他精神疾病的老年人进行临床评估时,痴呆的较高基线风险值得牢记在心,当认知障碍出现时,应采取更高的谨慎态度,并注意不要认为这是固有的,除非有强有力的理由支持这一点。对于迟发性精神病,就像迟发性抑郁症一样,需要特别认真地考虑痴呆前症状的可能性。精神病学前驱症状被认为是路易体痴呆;然而,尽管它们很常见,但它们对其他痴呆症亚型的概念却很差(并且没有被“轻度行为障碍”概念充分捕获)。值得注意的是,Normark等人观察到的痴呆风险在精神病诊断年龄较大和痴呆症诊断年龄较小的人群中最强,这至少在一些个体中支持精神病作为前驱症状的重要作用。最后,显然还有更多的问题需要回答。虽然精神病和痴呆风险之间的关系可以从传统上包含在大型国家医疗保健数据库中的信息中确定,但下一组问题将需要更细粒度的数据资源。
{"title":"Psychosis and Dementia—Disorders of Disadvantage","authors":"Lucy Gibson,&nbsp;Christoph Mueller,&nbsp;Robert Stewart","doi":"10.1111/acps.70012","DOIUrl":"10.1111/acps.70012","url":null,"abstract":"&lt;p&gt;As any Old Age Psychiatrist will tell you, late-life affective and psychotic disorders are some of the least understood mental health conditions, particularly considering their impact and the large number of people affected. This lack of attention partly lies in the common mundane situation of overshadowing research interests. Mental health research in older adults focuses almost entirely on dementia, while research into affective and psychotic disorders focuses almost entirely on young adults. Unfortunately, lack of research translates into an impoverished evidence base, which in turn filters through to underrepresentation in healthcare policy, and this compounds the problem by reducing the likelihood of interest from research funders, impeding capacity building and perpetuating a vicious cycle of inattention which does no favours for patients or health services. Even within the field, there are inequalities in research evidence, with considerably more attention paid to late-onset syndromes than to those who may have been living with their earlier-onset condition for decades by the time they reach older age ranges.&lt;/p&gt;&lt;p&gt;However, considering late-life psychosis, overshadowing research priorities are only part of the problem, as the conditions themselves present sizeable intrinsic challenges. The social withdrawal that characterises late-onset psychosis limits the likelihood of people affected being represented in conventional recruited research samples or retained in any study involving follow-up [&lt;span&gt;1&lt;/span&gt;]. Furthermore, people with earlier-onset diagnoses are frequently out of contact with mental health services by the time they reach ‘older adult’ age ranges, so that it is difficult to identify potential participants for approaching in the first place. Conventional case control, cohort and intervention studies are therefore logistically formidable, if not wholly impractical and/or fundamentally limited by participation and/or attrition bias.&lt;/p&gt;&lt;p&gt;The growing availability of routine healthcare data for research provides important opportunities for improving the evidence base. Most national data governance frameworks permit the use of effectively anonymised healthcare information to be used for research which enables the better representation of populations who would previously have been considered ‘hard to reach’ in conventional recruited samples. This advantage is exemplified in the approach taken by Normark et al. [&lt;span&gt;2&lt;/span&gt;], described in this issue, using national data from Denmark to investigate dementia incidence in people with schizophrenia and related disorders (ICD-10 F2x) according to their age at first psychosis diagnosis or treatment. There are reasonable considerations about the required reliance on recorded diagnoses (given that both conditions may be under-diagnosed, particularly dementia, and that under-diagnosis is unlikely to be at random); however, it is difficult to see how the question could be addressed in a","PeriodicalId":108,"journal":{"name":"Acta Psychiatrica Scandinavica","volume":"152 3","pages":"153-155"},"PeriodicalIF":5.0,"publicationDate":"2025-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/acps.70012","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144574523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcriptomic and Neurotransmitter Insights Into Gray Matter Volume Changes From 1 Hz rTMS in Treating Schizophrenia With Auditory Verbal Hallucinations 从转录组学和神经递质角度观察1hz rTMS治疗伴有听觉言语幻觉的精神分裂症的灰质体积变化。
IF 5 2区 医学 Q1 PSYCHIATRY Pub Date : 2025-07-06 DOI: 10.1111/acps.70014
Yuanjun Xie, Chenxi Li, Muzhen Guan, Tian Zhang, Chaozong Ma, Lingling Wang, Xinxin Li, Yijun Li, Zhongheng Wang, Huaning Wang, Peng Fang

Background

Auditory verbal hallucinations (AVH) are prominent positive symptoms of schizophrenia that frequently prove resistant to conventional antipsychotic treatments. Low-frequency repetitive transcranial magnetic stimulation (rTMS) has emerged as a promising intervention for AVH; however, the underlying neurobiological mechanisms mediating its efficacy remain incompletely understood.

Methods

In this study, schizophrenia patients with AVH were randomly assigned to either an active stimulation group or a sham control group. The active stimulation group received 1 Hz rTMS targeting the left temporoparietal junction (TPJ), while the sham group underwent an identical procedure without actual stimulation. Structural MRI scans were conducted before and after treatment to evaluate changes in gray matter volume (GMV). Further analyses examined associations between GMV changes and both gene expression profiles and neurotransmitter receptor densities.

Results

Active rTMS stimulation resulted in a significant reduction in AVH symptoms and was associated with increased GMV in specific cortical regions related to sensory and cognitive processing. These structural changes correlated with gene sets enriched in neuroplasticity-related pathways, such as cell morphogenesis, chromatin remodeling, and vesicle cytoskeletal trafficking. Notable changes were also observed in neurotransmitter receptor densities, particularly for serotonin (5HT1a), dopamine (D1), and glutamate (mGluR5) receptors. Multiple linear regression analysis identified specific hub gene expressions, such as ANK1, and patterns of neurotransmitter density, especially mGluR5, as significant predictors of GMV changes following rTMS stimulation.

Conclusion

Low-frequency rTMS induced GMV changes, coupled with alterations in gene expression and neurotransmitter receptor densities, contribute to symptom alleviation in schizophrenia patients with AVH. These findings support rTMS as a promising intervention for targeting the neurobiological substrates underlying AVH in schizophrenia.

背景:听觉言语幻觉(AVH)是精神分裂症的突出阳性症状,通常对常规抗精神病药物有抗性。低频重复经颅磁刺激(rTMS)已成为一种有前途的干预AVH;然而,介导其功效的潜在神经生物学机制仍然不完全清楚。方法:将伴有AVH的精神分裂症患者随机分为积极刺激组和假对照组。主动刺激组接受针对左侧颞顶交界处(TPJ)的1 Hz rTMS,而假手术组接受相同的程序,但没有实际刺激。在治疗前后进行结构MRI扫描以评估灰质体积(GMV)的变化。进一步的分析检查了GMV变化与基因表达谱和神经递质受体密度之间的关系。结果:活跃的rTMS刺激导致AVH症状显著减轻,并与与感觉和认知加工相关的特定皮质区域的GMV增加有关。这些结构变化与神经可塑性相关通路中丰富的基因集相关,如细胞形态发生、染色质重塑和囊泡细胞骨架运输。神经递质受体密度也发生了显著变化,特别是血清素(5HT1a)、多巴胺(D1)和谷氨酸(mGluR5)受体。多元线性回归分析发现,特定中枢基因表达,如ANK1,以及神经递质密度模式,特别是mGluR5,是rTMS刺激后GMV变化的重要预测因素。结论:低频rTMS诱导的GMV改变,加上基因表达和神经递质受体密度的改变,有助于精神分裂症合并AVH患者症状的缓解。这些发现支持rTMS作为一种有希望的针对精神分裂症AVH的神经生物学基础的干预措施。
{"title":"Transcriptomic and Neurotransmitter Insights Into Gray Matter Volume Changes From 1 Hz rTMS in Treating Schizophrenia With Auditory Verbal Hallucinations","authors":"Yuanjun Xie,&nbsp;Chenxi Li,&nbsp;Muzhen Guan,&nbsp;Tian Zhang,&nbsp;Chaozong Ma,&nbsp;Lingling Wang,&nbsp;Xinxin Li,&nbsp;Yijun Li,&nbsp;Zhongheng Wang,&nbsp;Huaning Wang,&nbsp;Peng Fang","doi":"10.1111/acps.70014","DOIUrl":"10.1111/acps.70014","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Auditory verbal hallucinations (AVH) are prominent positive symptoms of schizophrenia that frequently prove resistant to conventional antipsychotic treatments. Low-frequency repetitive transcranial magnetic stimulation (rTMS) has emerged as a promising intervention for AVH; however, the underlying neurobiological mechanisms mediating its efficacy remain incompletely understood.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>In this study, schizophrenia patients with AVH were randomly assigned to either an active stimulation group or a sham control group. The active stimulation group received 1 Hz rTMS targeting the left temporoparietal junction (TPJ), while the sham group underwent an identical procedure without actual stimulation. Structural MRI scans were conducted before and after treatment to evaluate changes in gray matter volume (GMV). Further analyses examined associations between GMV changes and both gene expression profiles and neurotransmitter receptor densities.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Active rTMS stimulation resulted in a significant reduction in AVH symptoms and was associated with increased GMV in specific cortical regions related to sensory and cognitive processing. These structural changes correlated with gene sets enriched in neuroplasticity-related pathways, such as cell morphogenesis, chromatin remodeling, and vesicle cytoskeletal trafficking. Notable changes were also observed in neurotransmitter receptor densities, particularly for serotonin (5HT1a), dopamine (D1), and glutamate (mGluR5) receptors. Multiple linear regression analysis identified specific hub gene expressions, such as ANK1, and patterns of neurotransmitter density, especially mGluR5, as significant predictors of GMV changes following rTMS stimulation.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Low-frequency rTMS induced GMV changes, coupled with alterations in gene expression and neurotransmitter receptor densities, contribute to symptom alleviation in schizophrenia patients with AVH. These findings support rTMS as a promising intervention for targeting the neurobiological substrates underlying AVH in schizophrenia.</p>\u0000 </section>\u0000 </div>","PeriodicalId":108,"journal":{"name":"Acta Psychiatrica Scandinavica","volume":"152 5","pages":"372-392"},"PeriodicalIF":5.0,"publicationDate":"2025-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144574524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationships of Cognitive Function With Subsequent Device-Measured Physical Activity and Sedentary Time in Healthy Individuals and Those With Bipolar Disorder: Findings From the UK Biobank. 健康个体和双相情感障碍患者的认知功能与随后设备测量的身体活动和久坐时间的关系:来自英国生物银行的发现
IF 5.3 2区 医学 Q1 PSYCHIATRY Pub Date : 2025-07-03 DOI: 10.1111/acps.70011
Elysha Ringin, David W Dunstan, Denny Meyer, Roger S McIntyre, Neville Owen, Michael Berk, Susan L Rossell, Mats Hallgren, Tamsyn E Van Rheenen

Background: In bipolar disorder (BD), physical inactivity and sedentary behaviour are prevalent and have been linked to BD's cognitive symptoms, although the directionality of these links is not clear. This proof-of-concept study examined whether cognitive function during mid- and later-life was prospectively related to physical activity and sedentary time, and whether the association differed in presence or extent between those with BD and healthy controls.

Methods: Relevant UK Biobank data were available for 646 BD participants and 18,041 psychiatrically healthy controls, aged 40-69 years at baseline. Cognition was assessed during a baseline assessment, and wrist-worn accelerometry data were collected at a follow-up assessment 2.8-6.6 years later. Regression analyses examined prospective relationships of global cognition, diagnostic group, and their interaction, with physical activity (total, light, and moderate to vigorous) and sedentary time.

Results: Baseline cognitive function was inversely associated with light physical activity (coeff. = -5.64, 95% CI: -6.30 to -4.98) and positively associated with sedentary time (coeff. = 5.17, 95% CI: 4.48-5.86) and moderate-to-vigorous physical activity (coeff. = 0.48, 95% CI: 0.28-0.68) at follow-up. Observed effect sizes were small but significant. In general, associations were not moderated by age or diagnostic group.

Conclusions: The current study provides preliminary evidence that cognitive function may influence subsequent physical activity and sedentary time similarly in those with BD and healthy controls; however, further research is needed to confirm and further explore this findings.

背景:在双相情感障碍(BD)中,缺乏运动和久坐行为是普遍存在的,并且与BD的认知症状有关,尽管这些联系的方向性尚不清楚。这项概念验证研究调查了中年和晚年的认知功能是否与身体活动和久坐时间有关,以及双相障碍患者和健康对照者之间这种关联的存在或程度是否不同。方法:646名BD参与者和18041名精神健康对照者的相关UK Biobank数据,基线年龄为40-69岁。在基线评估中评估认知能力,并在2.8-6.6年后的随访评估中收集腕带加速度计数据。回归分析检验了整体认知、诊断组及其相互作用与身体活动(总运动量、轻度运动量、中度至剧烈运动量)和久坐时间的潜在关系。结果:基线认知功能与轻度体力活动呈负相关(coeff. = -5.64, 95% CI: -6.30至-4.98),与久坐时间呈正相关(coeff. = -4.98)。= 5.17, 95% CI: 4.48-5.86)和中高强度体力活动(coff = 0.48, 95% CI: 0.28-0.68)。观察到的效应量虽小但显著。总的来说,这种关联不受年龄或诊断组的影响。结论:目前的研究提供了初步证据,表明认知功能可能会影响双相障碍患者和健康对照者随后的身体活动和久坐时间;然而,需要进一步的研究来证实和进一步探索这一发现。
{"title":"Relationships of Cognitive Function With Subsequent Device-Measured Physical Activity and Sedentary Time in Healthy Individuals and Those With Bipolar Disorder: Findings From the UK Biobank.","authors":"Elysha Ringin, David W Dunstan, Denny Meyer, Roger S McIntyre, Neville Owen, Michael Berk, Susan L Rossell, Mats Hallgren, Tamsyn E Van Rheenen","doi":"10.1111/acps.70011","DOIUrl":"https://doi.org/10.1111/acps.70011","url":null,"abstract":"<p><strong>Background: </strong>In bipolar disorder (BD), physical inactivity and sedentary behaviour are prevalent and have been linked to BD's cognitive symptoms, although the directionality of these links is not clear. This proof-of-concept study examined whether cognitive function during mid- and later-life was prospectively related to physical activity and sedentary time, and whether the association differed in presence or extent between those with BD and healthy controls.</p><p><strong>Methods: </strong>Relevant UK Biobank data were available for 646 BD participants and 18,041 psychiatrically healthy controls, aged 40-69 years at baseline. Cognition was assessed during a baseline assessment, and wrist-worn accelerometry data were collected at a follow-up assessment 2.8-6.6 years later. Regression analyses examined prospective relationships of global cognition, diagnostic group, and their interaction, with physical activity (total, light, and moderate to vigorous) and sedentary time.</p><p><strong>Results: </strong>Baseline cognitive function was inversely associated with light physical activity (coeff. = -5.64, 95% CI: -6.30 to -4.98) and positively associated with sedentary time (coeff. = 5.17, 95% CI: 4.48-5.86) and moderate-to-vigorous physical activity (coeff. = 0.48, 95% CI: 0.28-0.68) at follow-up. Observed effect sizes were small but significant. In general, associations were not moderated by age or diagnostic group.</p><p><strong>Conclusions: </strong>The current study provides preliminary evidence that cognitive function may influence subsequent physical activity and sedentary time similarly in those with BD and healthy controls; however, further research is needed to confirm and further explore this findings.</p>","PeriodicalId":108,"journal":{"name":"Acta Psychiatrica Scandinavica","volume":" ","pages":""},"PeriodicalIF":5.3,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144558562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does Lithium Lower the Risk of Glaucoma—A Danish Nationwide Study 锂能降低青光眼的风险吗?
IF 5 2区 医学 Q1 PSYCHIATRY Pub Date : 2025-07-03 DOI: 10.1111/acps.70010
Tomas Hajek, Orestes Forlenza, Marcelo Nicolela, Ann-Eva Christensen, Henrik Vorum, René Ernst Nielsen

Background

Glaucoma is an optic neuropathy caused by neurodegenerative loss of retinal ganglion cells (RGC). Mechanisms that contribute to RGC death include some of the same mechanisms involved in bipolar disorders (BD) and are the same mechanisms which are targeted by lithium (Li). We conducted a pharmacoepidemiological, population study in Denmark testing the links between Li prescriptions and risk of glaucoma.

Study Design

A nationwide, register-based historical, prospective cohort study of participants who were alive and over the age of 18 between January 1, 1996 and December 31, 2019. Participants were followed from the start of study until censoring or glaucoma.

Study Results

A total of 7,683,398 individuals (51.3% females) contributing 121,366,461 person-years were included in the study. In the general population, Li exposure was associated with developing glaucoma (HR = 1.10, 95% CI = 1.02–1.19, p = 0.01), but this association was not present in the population with BD (HR = 1.07, 95% CI = 0.93–1.22, p = 0.34). In the cumulative dosage analyses of the entire population, people with no Li prescription (HR = 0.78 95% CI = 0.66–0.93, p = 0.01) and between 365 defined daily doses (DDDs) and 5 × 365 DDDs of Li showed significantly reduced risk of glaucoma, relative to at least one prescription (HR = 0.79, 95% CI = 0.64–0.99, p < 0.05).

Conclusion

BDs as indexed by Li prescription are associated with a greater risk of glaucoma. This is in keeping with generally increased rates of medical comorbidities in BD. While there was no clear dose–response relationship, some of the higher cumulative exposures to Li might be protective relative to a single prescription.

背景:青光眼是一种由视网膜神经节细胞退行性丧失引起的视神经病变。导致RGC死亡的机制包括一些与双相情感障碍(BD)相同的机制,并且与锂(Li)靶向的机制相同。我们在丹麦进行了一项药物流行病学和人口研究,测试Li处方与青光眼风险之间的联系。研究设计:一项全国性的、基于登记册的历史前瞻性队列研究,研究对象是1996年1月1日至2019年12月31日期间18岁以上的在世参与者。参与者从研究开始一直被跟踪到青光眼。研究结果:该研究共纳入7683398人(51.3%为女性),共121366461人年。在一般人群中,Li暴露与青光眼相关(HR = 1.10, 95% CI = 1.02-1.19, p = 0.01),但这种关联在BD人群中不存在(HR = 1.07, 95% CI = 0.93-1.22, p = 0.34)。在整个人群的累积剂量分析中,没有Li处方的人群(HR = 0.78 95% CI = 0.66-0.93, p = 0.01),在365限定日剂量(DDDs)和5 × 365 DDDs之间的人群,相对于至少一个处方(HR = 0.79, 95% CI = 0.64-0.99, p),青光眼的风险显著降低(HR = 0.79, 95% CI = 0.64-0.99)。这与双相障碍的医学合并症发生率普遍上升是一致的。虽然没有明确的剂量-反应关系,但相对于单一处方,一些较高的Li累积暴露可能具有保护作用。
{"title":"Does Lithium Lower the Risk of Glaucoma—A Danish Nationwide Study","authors":"Tomas Hajek,&nbsp;Orestes Forlenza,&nbsp;Marcelo Nicolela,&nbsp;Ann-Eva Christensen,&nbsp;Henrik Vorum,&nbsp;René Ernst Nielsen","doi":"10.1111/acps.70010","DOIUrl":"10.1111/acps.70010","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Glaucoma is an optic neuropathy caused by neurodegenerative loss of retinal ganglion cells (RGC). Mechanisms that contribute to RGC death include some of the same mechanisms involved in bipolar disorders (BD) and are the same mechanisms which are targeted by lithium (Li). We conducted a pharmacoepidemiological, population study in Denmark testing the links between Li prescriptions and risk of glaucoma.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Study Design</h3>\u0000 \u0000 <p>A nationwide, register-based historical, prospective cohort study of participants who were alive and over the age of 18 between January 1, 1996 and December 31, 2019. Participants were followed from the start of study until censoring or glaucoma.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Study Results</h3>\u0000 \u0000 <p>A total of 7,683,398 individuals (51.3% females) contributing 121,366,461 person-years were included in the study. In the general population, Li exposure was associated with developing glaucoma (HR = 1.10, 95% CI = 1.02–1.19, <i>p</i> = 0.01), but this association was not present in the population with BD (HR = 1.07, 95% CI = 0.93–1.22, <i>p</i> = 0.34). In the cumulative dosage analyses of the entire population, people with no Li prescription (HR = 0.78 95% CI = 0.66–0.93, <i>p</i> = 0.01) and between 365 defined daily doses (DDDs) and 5 × 365 DDDs of Li showed significantly reduced risk of glaucoma, relative to at least one prescription (HR = 0.79, 95% CI = 0.64–0.99, <i>p</i> &lt; 0.05).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>BDs as indexed by Li prescription are associated with a greater risk of glaucoma. This is in keeping with generally increased rates of medical comorbidities in BD. While there was no clear dose–response relationship, some of the higher cumulative exposures to Li might be protective relative to a single prescription.</p>\u0000 </section>\u0000 </div>","PeriodicalId":108,"journal":{"name":"Acta Psychiatrica Scandinavica","volume":"152 4","pages":"308-315"},"PeriodicalIF":5.0,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/acps.70010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144558561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta Psychiatrica Scandinavica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1